Ken Griffin A Tyr Pharma Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 15,500 shares of LIFE stock, worth $28,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,500

Previous 200 7650.0%

Holding current value

$28,830

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.24 $1.33 Million - $1.97 Million	-878,655 Reduced 47.62%	966,607 $1.8 Million
Q2 2024 Aug 14, 2024	SELL	$0.0 - $2.07 $0 - $120,233	-58,084 Reduced 3.05%	1,845,262 $2.88 Million
Q1 2024 May 15, 2024	BUY	$1.42 - $2.02 $212,639 - $302,486	149,746 Added 8.54%	1,903,346 $3.71 Million
Q4 2023 Feb 14, 2024	SELL	$1.11 - $1.51 $33,894 - $46,109	-30,536 Reduced 1.71%	1,753,600 $2.47 Million
Q3 2023 Nov 14, 2023	BUY	$1.55 - $2.23 $2.27 Million - $3.26 Million	1,464,046 Added 457.39%	1,784,136 $2.82 Million
Q2 2023 Aug 14, 2023	BUY	$1.72 - $2.57 $480,156 - $717,443	279,161 Added 682.06%	320,090 $691,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.5 $5,812 - $7,730	3,092 Added 8.17%	40,929 $85,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $2.49 $76,430 - $94,214	37,837 New	37,837 $82,000
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $159,471 - $253,140	-33,573 Reduced 17.35%	159,921 $855,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $50,454 - $65,749	-6,921 Reduced 3.45%	193,494 $1.45 Million
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $719,687 - $2.13 Million	170,542 Added 570.89%	200,415 $1.82 Million
Q2 2021 Aug 16, 2021	BUY	$3.62 - $4.88 $59,378 - $80,046	16,403 Added 121.77%	29,873 $145,000
Q1 2021 May 17, 2021	BUY	$3.53 - $8.06 $47,549 - $108,568	13,470 New	13,470 $60,000
Q3 2020 Nov 16, 2020	SELL	$3.23 - $5.39 $38,753 - $64,669	-11,998 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.55 - $4.58 $16,847 - $30,260	-6,607 Reduced 35.51%	11,998 $53,000
Q1 2020 May 15, 2020	BUY	$2.17 - $7.06 $10,483 - $34,106	4,831 Added 35.07%	18,605 $52,000
Q4 2019 Feb 14, 2020	BUY	$3.03 - $4.83 $41,735 - $66,528	13,774 New	13,774 $57,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account